SHOULDER & ELBOW
No difference between PRP and lidocaine injection in addition to tenotomy for elbow tendinopathy
J Orthop Surg Res. 2019 Apr 23;14(1):109. doi: 10.1186/s13018-019-1153-680 patients with elbow tendinopathy and scheduled for needle tenotomy were randomized to adjuvant intratendinous injection or either platelet-rich plasma or lidocaine. Intratendinous injections were performed within areas of hypoechogenicity observed during ultrasound-guided tenotomy. Primary outcomes were the proportion of patients who demonstrated minimum reductions of 25% from baseline in the Disabilities of the Arm, Shoulder, and Hand (DASH) and pain on a visual analog scale (VAS). Results demonstrated no significant differences between groups in responders for both measures from 6 weeks to 1 year following treatment.
Unlock the full ACE Report
You have access to {0} free articles per month.Click below to unlock and view this {1}
Unlock NowCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidence content for just $1.99 per week.
Already have an account? Log in
Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
{0} of {1} free articles
Become an OrthoEvidence Premium Member. Expand your perspective with high-quality evidence.
Upgrade Now
